Johnson & Johnson Stock - weekly review and sector check
Published on 06/19/2026 at 15:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Sector & Peer-Group Desk. Verified prior to publication on 06/19/2026, 13:00 UTC. Details in the imprint.
Johnson & Johnson (US4781601046) is ending the week with a modest pullback after a strong prior run. The move comes as large US healthcare names show a softer tone alongside a recent downtick in the broader market, according to sector data.
All news and key figures on Johnson & Johnson stock
Find more background, filings and market data on Johnson & Johnson, from earnings and guidance to dividend history and index membership.
How the week shaped up
Johnson & Johnson shares recently closed around $228 on the New York Stock Exchange, down roughly 2.5% from the prior session’s close, based on delayed quote data as of 06/18/2026.
That leaves the stock still comfortably above the $200 level seen earlier this year, highlighting a solid year-to-date performance despite the latest step back.
Peer comparison in healthcare
On a weekly view, the decline in Johnson & Johnson mirrors a softer patch for large US healthcare and pharmaceutical names, with several blue chips also edging lower in recent sessions according to sector screens.
Overall, the stock’s market capitalization remains around $550 billion, keeping Johnson & Johnson among the largest constituents of the Standard & Poor's 500 index and a heavyweight in global healthcare benchmarks.
How the company makes money
Johnson & Johnson generates revenue across three main segments: innovative medicines, medtech devices and consumer health products, including well-known brands such as Tylenol and Band-Aid, according to the company’s latest corporate overview.
Where the stock trades today
The shares of Johnson & Johnson (US4781601046) trade on the New York Stock Exchange at $228.38 as of 06/18/2026, 16:00 ET.
Key facts on Johnson & Johnson stock
- Company: Johnson & Johnson Inc.
- ISIN: US4781601046
- WKN: 853260
- Ticker: JNJ
- Venue: NYSE
- Price (as of 06/18/2026, 16:00 ET): 228.38 USD
- Market cap: 549,600,000,000 USD (as of 06/18/2026)
- Sector / Industry: Health Care / Pharmaceuticals & Medical Devices
- Index membership: Dow Jones Industrial Average, S&P 500
- Next earnings date: 07/16/2026
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
